Bayer Shares Drop 2% Over Roundup Lawsuit

Bayer AG shares fell over 2% after U.S. Supreme Court heard arguments on a Roundup cancer liability case.
The company seeks to overturn a $1.25 million Missouri jury verdict alleging glyphosate caused non‑Hodgkin lymphoma.
Bayer has spent more than $10 billion settling Roundup-related lawsuits since acquiring Monsanto in 2018.
The Supreme Court will rule by June/early July, potentially affecting thousands of similar lawsuits nationwide.